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Abstract
Introduction: Lymphocyte homeostasis is dependent on the gc cytokines. We hypothesised that sepsis in humans
is associated with differential gene expression of the gc cytokines and their associated apoptosis mediators.
Methods: The study population consisted of a total of 60 patients with severe sepsis, 15 with gram negative
bacteraemia, 10 healthy controls and 60 patients undergoing elective lung resection surgery. Pneumonia was
diagnosed by CDC NNIC criteria. Gene expression in peripheral blood leukocytes (PBLs) of interleukin (IL)-2, 7, 15
and interferon (IFN)-g, Bax, Bim, Bcl-2 was determined by qRT-PCR and IL-2 and IL-7 serum protein levels by ELISA.
Gene expression of IL-2, 7 and IFN-g was measured in peripheral blood leukocytes (PBL), cultured in the presence
of lipopolysacharide (LPS) and CD3 binding antibody (CD3ab)
Results: IL-2 gene expression was lower in the bacteraemia group compared with controls, and lower still in the
sepsis group (P < 0.0001). IL-7 gene expression was similar in controls and bacteraemia, but lower in sepsis (P <
0.0001). IL-15 gene expression was similar in the three groups. Bcl-2 gene expression was less (P < 0.0001) and Bim
gene expression was greater (P = 0.0003) in severe sepsis compared to bacteraemic and healthy controls. Bax gene
expression was similar in the three groups.
In lung resection surgery patients, post-operative pneumonia was associated with a perioperative decrease in IL-2
mRNA (P < 0.0001) and IL-7 mRNA (P = 0.003). IL-2 protein levels were reduced in sepsis and bacteraemia
compared to controls (P = 0.02) but similar in pneumonia and non-pneumonia groups. IL-7 protein levels were
similar in all groups.
In cultured PBLs, IFN-g gene expression was decreased in response to LPS and increased in response to CD3ab
with sepsis: IL-7 gene expression increased in response to LPS in controls and to CD3ab with sepsis; Bcl-2 gene
expression decreased in response to combined CD3ab and IL-2 with sepsis.
Conclusions: Patients with infection and sepsis have deficient IL-2 and IL-7 gene expression in PBLs. Aberrant
cytokine gene expression may precede the onset of infection.
Introduction
The gamma chain (gc) family of interleukins (IL) that
includes IL-2, IL-7, IL-15 and IL-21, regulate lympho-
cyte homeostasis. These cytokines act on distinct lym-
phocyte populations; IL-2 is a T cell growth factor,
contributes to the development of regulatory T (T reg)
cells [1]; IL-7 is critical for T and B cell development
and is a potent lymphocyte survival factor [2]; IL-15 is a
trophic factor for NK cells and CD8+ T cell homeostasis
[3]. The cellular effects of IL-2 and IL-7 are mediated
by regulating Bcl-2, Bax and Bim mediated apoptosis
[4,5].
This group has previously shown a link between effec-
tor cytokine gene expression in peripheral blood leuko-
cytes (PBL) and human response to infection and
patient response to surgery [6-10]. In these studies
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cytokine gene expression was assayed by reverse tran-
scriptase polymerase chain reaction according to an
established protocol [11]. This approach provides a
unique in vivo insight to PBL function in humans that
may not be reflected by cytokine protein levels in per-
ipheral blood, as these proteins may emanate from a
diverse range of other cells. However, these cytokine
gene expression patterns did not include cytokines
which regulate T cell homeostasis, and consequently did
not account for the profound lymphocyte apoptosis
reported in animal models of sepsis and in humans
[12-14]. It is plausible that cytokines involved in regulat-
ing T cell homeostasis are involved in the immune defi-
ciency linked with sepsis. Furthermore, the onset and
evolution or resolution of sepsis may be related to dys-
regulation of these cytokines. We hypothesised the
gamma c cytokine mediated response may be important
in both the predisposition and occurrence of infection
and sepsis in humans. Our primary endpoint was to
determine whether sepsis in humans was associated
with differential gene expression of gamma c family of
cytokines. A secondary endpoint was to determine
whether any differential gene expression of the gamma c
cytokines preceded the clinical onset of infection.
We report gene expression of the gc cytokines and
associated regulators of apoptosis in PBLs of patients
with sepsis, and gene expression in lung resection sur-
gery patients. We also investigated the effect of exogen-
ous IL-2 on cytokine gene expression in cultured
mononuclear cells to determine whether IL-2 might
plausibly be considered as an immune adjuvant for
patient with sepsis. While we could link changes in
cytokine gene expression to the occurrence of sepsis in
response to infection, we were not clear whether this
was an epiphenomenom, or was causal in nature. To
clarify this issue we needed to study a group of patients
who were likely to develop infection and study cytokine
gene expression prior to the onset of infection. Thus,
we chose thoracic surgery patients as a group with rela-
tively frequent occurrence of post-operative pneumonia
[15], in which we could draw blood samples before and
after surgery, but prior to the onset of infection. Our
results indicate that the occurrence of infection and sep-
sis are linked with deficient gc family cytokines gene
expression, specifically IL-2 and IL-7.
Materials and methods
Patient groups
Established infection (sepsis, bacteraemia)
We studied 60 consecutive patients presenting with
severe sepsis or septic shock attending St. James’s Hos-
pital, Dublin. All patients met the criteria as defined by
the American College of Chest Physicians/Society of
Critical Care Conference [16]. Ethical approval for this
study was obtained from the Ethics Committee of St.
James’s Hospital and informed written consent was
obtained from each patient or relative. Exclusion criteria
included the following: (1) pre-existing overt organ fail-
ure, (2) infection with human immunodeficiency virus,
(3) patients with neutropenia as a result of chemother-
apy, (4) patients receiving long-term treatment with
steroids, (5) patients with trauma and burns, and (6)
patients with non-Irish Caucasian ethnic background.
Severity of illness was characterized upon admission to
ICU using the Simplified Acute Physiology Score (SAPS
II) [17] and the Sequential Organ Failure Assessment
(SOFA) [18] scoring systems and again on Day 7. Clini-
cal and laboratory variables were collected on Day 1 and
again on Day 7 in survivors. The source of infection
precipitating ICU admission and the pathogenic organ-
isms were documented. ICU death or survival to ICU
discharge was recorded.
Fifteen consecutive patients, admitted to hospital with
a documented Gram-negative bacteraemia on blood cul-
ture were enrolled if no organ failure or impending sep-
tic crisis was identified. Ten healthy staff members were
identified as a control group.
Prospective infection cohort
A second study population consisting of 60 patients who
underwent thoracotomy for lung resection surgery for
non-infectious disease and without signs of acute
respiratory infection were enrolled. Patients with pre-
existing immunosuppression and those treated with anti
microbials in the week preceding surgery were excluded.
Postoperative patient care was provided by the primary
care service in accordance with the established patient
care pathways in our institution and without reference
to the investigators. The diagnosis of post-operative
pneumonia (POP) in the first week after surgery was
based on the Center for Disease Control and Prevention
definition [19].
Blood sampling
EDTA anticoagulated blood samples were taken within
the first 24 h of ICU admission and again seven days
later in the ICU patients. In bacteraemic patients, blood
sampling was carried out within 24 h of the positive
blood culture being reported. Blood samples were col-
lected from controls at one time point. In the thoracot-
omy group, whole blood sampling was collected
preoperatively (Day 0) and again 24 h (Day 1) and five
days (Day 5) postoperatively. PBLs were prepared by
density gradient centrifugation using Lymphoprep
(Nycomed Pharma, Oslo, Norway). For RNA extraction,
PBLs were lysed with RLT lysis buffer (Qiagen, West
Sussex, England) and stored at -80°C. For flow cytome-
try, PBLs were used immediately. Serum was obtained
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from whole blood clotted for 30 minutes, and stored at
-80°C until analysis.
Total RNA was isolated from lysed PBLs using a
commercially available kit (Qiagen) following the manu-
facturer’s instructions. To avoid amplification of con-
taminating genomic DNA, all samples were treated with
RNase-free DNase (Qiagen) for 15 minutes. The quan-
tity and purity of extracted RNA was measured by spec-
trophotometry (Eppendorf BioPhotometer, Hamburg,
Germany).
Total RNA was reverse transcribed as previously
described [11]. The PCR reactions were carried out in
an ABI Prism 7000 (Applied Biosytems, Foster City, CA,
USA) and all reactions were performed in triplicate as
previously described [11]. Primers and probes used in
this study were synthesized at Applied Biosystems. b-
Actin, IL-2, IL-7, IL-15, IL-21, Bcl-2, Bim, Bax primers
and probes were designed and customised as per Stor-
deur et al. [11]. The DNA standards for b-Actin, IL-2,
IL-7, IL-15, IL-21, Bim, Bax, Bcl-2 consisted of a cloned
PCR product that included the quantified amplicon pre-
pared by PCR from a cDNA population containing the
target mRNA as per Stordeur et al. [11]. To quantify
transcript levels a standard curve was constructed, for
each PCR run, for each selected mRNA target from
serial dilutions of the relevant standard as previously
described [11]. Results were then expressed in absolute
copy numbers after normalisation against b-Actin
mRNA (mRNA copy numbers of cytokine mRNA per
10 million b-Actin mRNA copy numbers). Normalisa-
tion calculation = (Target Gene Copy Number/b-Actin
Copy Number)*7.
Cytokine serum protein measurement by Enzyme Linked
Immunosorbant Assay (ELISA)
Serum was collected from patients and controls at the
same timepoints as blood was collected for gene expres-
sion. Serum IL-2 and IL-7 concentrations were mea-
sured by in triplicate by ELISA (R&D Systems,
Minneapolis, MN, USA). The lower limit of detection of
IL-2 was 11.2 pg/mL and IL-7 was 0.50 pg/mL.
In vitro stimulation of peripheral blood leukocytes
Blood samples were collected from five healthy controls
and five patients with severe sepsis. PBLs were isolated
and cultured in 24-well plates at 106 cells/ml in RPMI
1640 supplemented with 10% (vol/vol) FCS and 2 mM
glutamine 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES). Cells were incubated in medium alone or
stimulated with either 1 μg/ml lipopolysaccharide (LPS)
(Control LPS and Sepsis LPS) for 24 h (to activate
monocytes and B cells), 3 μg/ml anti-CD3 monoclonal
antibody (aCD3ab) (Control CD3 and Sepsis CD3) for 4
h (to activate T cells), or 10 ng/ml phorbol myristate
acetate + 1 μM ionomycin (PMA+iono) (Control PMA
and Sepsis PMA) for 4 h (to activate all cells). Each
experiment was performed in the absence and presence
of 50 U recombinant IL-2 (rIL-2). 2 × 105 PBLs were
harvested immediately for flow cytometry and remaining
cells were lysed. Total RNA was isolated; reverse tran-
scribed as previously described [11] and mRNA assayed
for IFN-g, IL-2, IL-7 and Bcl-2.
Flow cytometry
Flurochrome-labelled monoclonal antibodies specific for
CD3, CD4, CD8, CD56, CD127, CD25, CD19, IFN-g
and IL-2 and isotype-matched control antibodies were
obtained from BD Biosciences. PBLs (2 × 105) were
stained for cell surface antigen expression at 4°C in the
dark for 30 minutes, then washed twice in 2 mL phos-
phate-buffered saline containing 1% bovine serum albu-
min and 0.01% sodium azide (FACS Wash) and
subsequently fixed in 200 μL of 1% paraformaldehyde
(Sigma-Aldrich, Arklow, Ireland). Isotype-matched fluor-
escently-labelled control antibodies were used to deter-
mine background levels of staining. Lymphocytes and
monocytes were identified by characteristic forward
scatter and side scatter parameters and T cells, NK cells
and monocytes were defined as CD3+, CD3-CD56+ and
CD14+ populations, respectively. Results are expressed
as % positive of gated population.
Statistical analysis
The Wilcoxon rank sum test was used to analyse the
differences between groups for continuous variables.
Categorical variables were analysed by Chi Square test
and Fishers exact test as appropriate. Results from cell
culture experiments were analysed with a fully factorial
MANOVA, with post hoc contrast to identify differ-
ences between control and septic patients, where multi-
variate analysis identifying a difference between these
Table 1 Patient demographics of the three study groups,
sepsis (n = 60), bacteraemia (n = 15) and healthy
controls (n = 10)
Sepsis Bacteraemia Control P
N 60 15 10
Age 54 (72 to 80) 73 (70 to 82) ns
Gender (Female) 27 (48%) 9 (60%) ns
Apache 25 (21 to 28) 7 (6 to 8) 0.0001
SOFA 10 (12 to 14) 1 (1 to 2) 0.0001
Septic Shock 58 (98%) 0 0.0001
Mortality 18 (30%) 0 0.002
Respiratory Infection 25 (42%) 2 (13%)
Abdominal Infection 28 (48%) 4 (27%)
Urinary 0 6 (40%)
Other Infection 6 (10%) 3 (20%) 0.0001
Patient demographics of the three study groups, Sepsis (n = 60), Bacteraemia
(n = 15) and Healthy Controls (n = 10). N denotes number in each group. All
continuous values are median and inter-quartile range. Categories are stated
as absolute numbers with percentages in parentheses. Apache, Acute
Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure
Assessment.
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groups. Data analysis was performed using the JMP sta-
tistical package (SAS, Cary, NC, USA).
Results
Demographic variables, site of infection and severity of
illness scores from 60 septic, 15 bacteraemic and 10
healthy controls are given in Table 1. IL-2 gene expres-
sion was lower in bacteraemia patients compared with
controls, and lower still in patients with sepsis (Figure
1); IL-7 gene expression was similar in control and bac-
teraemic patients, but lower in patients with sepsis; IL-
15 gene expression was similar in the three groups. IL-
21 mRNA was not detected in PBLs of any study
groups. There was no relation between gender, age and
IL-2 and IL-7 mRNA levels.
Bcl-2 gene expression was greatest in bacteraemic
patients, intermediate in controls and the least in septic
patients; Bim gene expression was increased in sepsis
compared to bacteraemia and controls; Bax gene expres-
sion was similar in all three groups (Figure 1).
There was no relation between severity of organ fail-
ure and/or outcome in patients with sepsis and IL-2,
IL-7, IL-15, Bim, Bax or Bcl-2 gene expression.
IL-2 protein levels were greater in healthy controls
compared to patients with established infection (Figure
2). IL-7 protein levels were similar in the three groups.
There was no correlation between cytokine mRNA
levels and respective cytokine protein levels. There was
no relation between survival or severity of organ failure
and cytokine protein levels.
Demographic variables, functional impairment scores
and information on the type of surgery performed for 60
elective thoracic surgery patients are given in Table 2. In
thoracic surgery patients, POP was associated with
reduced IL-2 gene expression on the first day after sur-
gery and lower IL-7 gene expression on the fifth day after
surgery (Figure 3). When the relative changes in cytokine
mRNA were considered, there was a significant link
between a decrease in IL-2 and IL-7 gene expression on
the first day after surgery and the subsequent occurrence
of POP (Table 3). Allowing for the multiple comparisons
of cytokine gene transcription, at three time points, the
perioperative change in IL-2 would still retain statistical
significance while the significance of change in IL-7
would be borderline.
Pre-operative IL-2 and IL-7 mRNA values of patients
in the thoracic surgery study were compared with
patients in the sepsis study. Median Pre-operative IL-2
mRNA copy numbers were similar to those of bacterae-
mic patients, less than healthy controls, and greater than
patients with sepsis (Wilcoxon rank sum test P <
0.0001). Median Pre-operative IL-7 mRNA copy num-
bers were similar to those of bacteraemic patients and
healthy controls, and greater than patients with sepsis
(Wilcoxon rank sum test P < 0.0001). Median Pre-
operative Bcl-2 mRNA copy numbers were similar to
those of bacteraemic patients and healthy controls, and
greater than patients with sepsis (Wilcoxon rank sum
test P < 0.0001). Bax mRNA levels were similar in all
four groups.
Serum IL-2 and IL-7 protein levels were similar in
POP and non POP groups both before surgery and Day
1 and Day 5 after surgery.
Cell surface expression of the IL-2 receptor in T cells
CD4+CD25+was similar in sepsis and control samples
(Table 4). The IL-7 receptor, CD127+, expression is
increased on CD3+lymphocytes from patients with sepsis
but reduced on NK cells compared to control samples
(Table 4).
In PBL cultures there was no significant difference in
IFN-g gene expression between patient groups. There
was a significant relationship between the type of exo-
genous stimulation and IFN-g gene expression (P =
0.0001); there was a significant interaction between
patient group and type of stimulation (P = 0.0002).
Thus IFN-g gene expression was lower in the PBLs of
patients with sepsis in the presence of LPS, and IFN-g
gene expression was higher in PBLs of patients with
sepsis in the presence of CD3ab (Figure 4).
In PBL cultures there was no significant difference in
IL-7 gene expression between patient groups (Figure 4).
However there was a significant relation between IL-7
gene expression and stimulus type, with IL-7 expression
greater in the presence of LPS compared with control
medium (P = 0.002). The interaction between patient
Group and Stimulus type had a significant effect on IL-7
gene expression (P = 0.04), as in the presence of CD3ab,
IL-7 gene expression was greater in PBLs from patients
with sepsis than in control samples (P = 0.005).
When cultured PBLs of patients with sepsis and healthy
controls were compared, there was no significant differ-
ence in IL-2 gene expression between patient Groups.
There was a significant difference in IL-2 gene expression
with Stimulus type (P = 0.002), with IL-2 gene expression
greater in the presence of PMA compared with a control
medium (P = 0.0002). The interaction between patient
Group and type of Stimulus had no effect on IL-2 gene
expression.
In parallel cultures in the presence of rIL-2, there was
no significant difference in IFN-g. IL-7, or IL-2 gene
expression between Groups or with exogenous Stimuli
(Figure 4).
There was no relation between Bcl-2 gene expression
and patient Group or exogenous Stimulus. In parallel
cultures in the presence of rIL-2, there was an interac-
tion between patient Group and exogenous Stimulus
which had a significant effect on Bcl-2 gene expression,
(P = 0.0008) (Figure 4). On post hoc testing Bcl-2 gene
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Figure 1 Cytokine gene expression levels in sepsis (n = 60), bacteraemia (n = 15) and controls (n = 10) as measured with qRT-PCR. IL-
2, IL-17, IL-15, IFN-g, Bcl-2, Bim and Bax are expressed as copy numbers of cytokine mRNA normalised to per 10 million b-Actin mRNA copy
numbers. Values represented as medians and centiles 10 to 90% in parenthesis. Between groups analysis is by Wilcoxon Rank Sum test. Pairwise
comparisons between control and bacteraemic (*), control and sepsis (#), p values are indicated where positive.
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expression was significantly lower in PBLs of patients
with sepsis compared with controls, after culture in the
presence of aCD3ab and rIL-2 (P = 0.005).
Discussion
The onset of infection and subsequent occurrence of
sepsis is linked with anomalous gene expression of gc
cytokines IL-2 and IL-7. IL-2 the prototypical member
of the gc cytokine family, is secreted after T cell receptor
(TCR) stimulation [20] and acting as a T cell growth
factor [21], plays a pivotal role in the T cell phenotype
differentiation [22], contributing to the development of
regulatory T cells and immune tolerance [23]. IL-2 pro-
duced by T cells in an autocrine manner in the initial
stages of T cell activation, is essential for the generation
and maintenance of effector and memory cells [24]. The
actions of IL-2 are multi-faceted, as IL-2 has been
shown to induce apoptosis of activated T cells [25]. It is
plausible that the decrease in IL-2 gene expression
which we observed in patients with gram negative infec-
tion and sepsis may reflect a failure of T cell activation.
Cell culture experiments indicated that treatment with
exogenous IL-2 down regulated gene expression of the
anti apoptotic marker Bcl-2 in activated T cells of septic
patients. This effect of exogenous IL-2 may represent
activation induced leukocyte apoptosis, which is a well
described effect of IL-2 [25]. Furthermore, IL-2 attenu-
ated inducible IFN-g gene expression, which effect is
plausibly related to the pro apoptotic effects of IL-2 in
activated T cells. These data would preclude considera-
tion of IL-2 as a sepsis immune adjuvant, and contri-
butes to the increasing recognition that apoptotic
processes have a salient role in septic shock pathophy-
siology [26,27].
IL-7 is a recognised lymphocyte survival factor [28].
Produced by stromal and epithelial cells in the bone
marrow, by the thymus and by fibroblastic reticular cells
in T zones of secondary lymphoid organs, and by den-
dritic cells, IL-7 regulates T cell activation by dendritic
cells [29,30]. The bioavailability of IL-7 is determined
both by its production and consumption by CD4+ T
cells [2]. Thus lymphopenia in humans should be asso-
ciated with reciprocal increases in IL-7 levels [31]. In
this study lymphopenic patients with severe sepsis had
decreased IL-7 gene expression, compared to controls
and patients with infection. Direct T cell stimulation
increased IL-7 gene expression of PBLs from septic
patients rather than control subjects, suggesting that IL-
7 production by peripheral lymphocytes requires prior
lymphocyte activation. Excess IL-2 abolished this differ-
ence in IL-7 gene expression, which may also represent
a side effect of activation apoptosis. While IL-7 may
have the potential to reverse sepsis induced apoptosis
and rhIL-2 related apoptosis in PBL of septic patients,
this will require further investigation and is beyond the
scope of the current project.
IL-7 negatively regulates cell surface expression of its
cognate receptor CD-127 [32]. This receptor, CD-127, is
expressed on naive and memory T cells, but not on
effector T cells. In this study, patients with sepsis exhib-
ited a marked reduction in CD127-_ve T cells, which
includes the subpopulation of effector T cells, and sug-
gests that the characteristic lymphopenia of sepsis pri-
marily involves effector T cells. IL-7 regulates T cell
Figure 2 Cytokine protein levels in patients with sepsis (n =
56), bacteraemic (n = 15) and control (n = 10) study groups.
Interleukin-2 (IL-2) and Interleukin-7 (IL-7) are expressed as
picograms per milliliter (pg/mL). * denotes P-value < 0.05. N
denotes number of subjects in each group. All values are median
and interquartile range in parenthesis. Between group comparisons
is by Wilcoxon Rank Sum test.
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homeostasis in part by increasing the expression of Bcl-
2, and by inhibiting the expression of the pro-apoptotic
factors Bax and Bim [33,34]. While we observed differ-
ential gene expressionof Bcl-2 and Bim in patients with
sepsis, these effects were not obvious immediately after
surgery in the initial stages of infection.
In this study of adults with bacterial infection, IL-15
gene expression was similar in all patient groups. This is
not surprising as IL-15, in concert with IL-7, acts as a
regulator of CD8+ T cells, whose primary role is in the
immune response to viral infection, and not bacterial
infection [35]. Using a well-established qRT-PCR proto-
col we could not find any detectable IL-21 mRNA in
PBL’s of humans with sepsis, suggesting that IL-21 is
predominantly produced by lymphocytes populations
other than PBL’s and is not of pivotal importance in the
immune response to infection in adults. This is consis-
tent with existing literature which implicates IL-21 in
the pathogenesis of atoimmune diseases such SLE, dia-
betes and psoriasis [36,37].
IFN-g produced by Th1 CD4 cells and antigen present-
ing cells (APCs) augments phagocytic bactericidal activity
in patients with infection [38,39], and is a useful metric of
host immune response to infection, and we considered it
as such in the cell culture experiments. In this study
down-regulation of IFN-g gene expression was evident in
cultured PBLs of septic patients. Furthermore, the
reported attenuation of IFN-g gene expression in cultured
PBLs of patients with sepsis was corrected by direct T cell
stimulation, but was refractory to stimulation with mono-
ctye specific ligands. Thus, it seems plausible that the
observed down-regulation of IFN-g gene expression in
sepsis is indicative of defective antigen presentation by
APCs such as monocytes, rather than an intrinsic T cell
defect. It is notable that our attempt to circumvent this
defect in APC dysfunction using rIL-2 in cell cultures
failed, as this intervention appeared to augment pro apop-
totic signals and inhibited inducible IFN-g and IL-7
production.
The link between sepsis and lymphocyte apoptosis is
well established, with several investigators reporting
down-regulation of gene expression of the anti apoptotic
protein Bcl-2 and upregulation of gene expression of
antagonistic pro-apoptotic proteins, such as Bid and Bax.
In addition, there is evidence from animal sepsis models
that manipulation of these regulators of apoptosis may
improve outcome [40-42]. However, we noted that Bcl-2
and related genes were also dysregulated in patients with
infection, but to a lesser extent than in septic patients.
Furthermore, prior to the onset of infection we observed
changes in IL-2 and IL-7 gene expression without any
change in expression of the Bcl-2 related genes. As the
effects of IL-2 and IL-7 are mediated by regulating Bcl-2
and related genes, it is plausible that the reported changes
in Bcl-2 related genes in septic patients reflect underlying
changes in gene expression of the gamma chain family of
cytokines, specifically IL-2 and IL-7.
This study elaborates upon our existing knowledge of
the immune suppression which characterises sepsis. While
the severity of organ failure in septic patients can be
directly related to humeral factors, such as IL-6 and com-
plement [43,44], the concomitant immune suppression
Table 2 Patient demographic data in lung resection surgery study group
Non POP POP P
Gender, M/F 29/12 13/6 0.86
Age in years 64.5 +/- 1.34 63.7 +/- 1.9 0.74
Body Mass Index, kg/m2 25.9 +/- 0.92 27.65 +/- 1.35 0.29
Karnofsky index score, mean +/-SD 90.24 +/- 1.17 88.95 +/- 1.72 0.54
NSCLC, n (%) 24 (58%) 8 (47%) 0.82
Currently smoking 16 (39%) 8 (42%)
Recent Cessation 15 (36%) 8 (42%)
Non Smoker 10 (24%) 3 (16%) 0.18
Cardiovascular co morbidity, n (%) 14 (34%) 7(37%) 0.57
Preoperative FEV1, (%) 82.12 +/- 2.28 82.34 +/- 3.36 0.95
Type of operation Lobectomy 39 14 0.99
Pneumonectomy 2 5 0.03*
Neoadjuvant chemotherapy 5 (12.2%) 2 (10.5%) 0.96
Perioperative anti-microbial cover 41(100%) 19 (100%) ns
Anaesthesia time in minutes 233.0 +/- 40 238.6 +/- 52 0.51
One lung Ventilation time in minutes 85.5 +/- 14.9 88.0 +/- 9.6 0.19
Post-operative PPV 2 1 ns
Patient demographic data in lung resection surgery study group. Absence of post-operative pneumonia (non-POP); post-operative pneumonia (POP). Post-
operative positive pressure ventilation (Post-operative PPV). NSCLC, Non small cell lung cancer. Categories are stated as absolute numbers with percentages in
parentheses. Values given as mean +/- SD or number (%) unless otherwise indicated. FEV1, forced expiratory volume in one second.
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can be linked to dysregulation of the immune response by
PBL. Thus, in patients with sepsis, and who fail to recover
from sepsis, PBLs produce less of the effector cytokines
that enhance phagocytic bactericidal activity such as IFN-g
and TNFa. Furthermore, PBLs of septic patients exhibit
anaomolus production of cytokines mediating T cell acti-
vation [8]. In addition, surface expression of MHC class II
molecules is down-regulated in monocytes of septic
patients and septic patients who encounter nosocomial
infections [45]. Lastly, gene expression of the cytokines
required to maintain T cell homeostasis appears to be
deficient in the PBL of septic patients. Hence, in septic
patients there appears to be a complex multifactorial
Figure 3 Cytokine mRNA gene expression in thoracic surgery patients. Cytokine mRNA gene expression was analysed at baseline Day 0 (24
hours pre surgery), Day 1 (24 hours post surgery) and Day 5 after surgery. POP, post-operative pneumonia (N = 19). Non POP, non post-
operative pneumonia (N = 41). IL-2, IL-7, IL-15, Bcl-2 and Bim are expressed as copy numbers of cytokine mRNA per 10 million b-Actin mRNA
copy numbers. Values represented as medians and centiles 10 to 90% in parenthesis. Between groups analysis is by Wilcoxon Rank Sum test. N
denotes number of patients in each group.
Table 3 Relative Change in cytokine mRNA in the first 24
hours after surgery
POP Non POP P
IL-2 6.7 (2.1 to 28.1) 1.1 (0.3 to 4.7) < 0.0001
N 14 37
IL-7 1.3 (0.9 to 6.2) 0.9 (0.5 to 2.1) 0.003
N 18 41
Relative change in cytokine mRNA gene expression in first 24 hours after
surgery. These data represent the ratio of pre-operative mRNA to post-
operative mRNA; the preoperative value divided by the post-operative value.
All values are quotes as median and 10th to 90th centile range. POP, post-
operative pneumonia, Non POP, uneventful recovery; mRNA, messenger
ribonucleic acid. Comparison is by Mann Whitney. N denotes the number of
patients in each group.
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Table 4 Cell surface antigen staining % total peripheral blood leukocytes
Control Sepsis P
N 5 5
Monocytes 4.9 (2.5 to 6.9) 5.2 (2.7 to 7.1) 0.9
Lymphocytes
iNKT 0.8 (0.2 to 1.0) 0.2 (0.1 to 0.7) 0.05*
B Cells 6.1(5.2 to 12.8) 16.2 (1.9 to 18.1) 0.62
NK cells 2.0 (0.1 to 8.0) 4.6 (0.6 to 12.7) 0.25
CD56+CD127+ 66.5 (62.7 to 73.9) 20.9 (3.9 to 53.9) 0.01*
CD56+ 1.6 (0.3 to 3.4) 0.6 (0.3 to 3.8) 0.40
CD3+ 83.9 (77.5 to 92.7) 61.3 (54.0 to 67.2) 0.009*
CD3+CD4+ 53.65 (25.7 to 66.4) 77.7 (65.5 to 84) 0.04*
CD3+CD4+CD25+ 19.85 (3.4 to 25.2) 11.4 (1.8 to 16.5) 0.25
CD3+CD8+ 30.7 (19.5 to 45.9) 16.1 (14.4 to 33.6) 0.14
CD3+CD127+ 80.5 (49.3 to 89.3) 97.2 (87.2 to 98.6) 0.01*
Cell surface antigen staining % total peripheral blood leukocytes. All values are quoted as percentage values of total peripheral blood leukocytes. All lymphocyte
subsets are quoted as total gated lymphocytes. All values are quoted as median and 10th to 90th centile range. CD4+CD25+, CD4+, CD8+ are quoted as
percentages of T Lymphocytes. NK, natural killer cells, iNKT cells; Between group comparison is by Mann Whitney.
Figure 4 Cytokine mRNA gene expression after in vitro stimulation of PBLs from septic (n = 5) and control (n = 5) patients. Interleukin
(IL) -2, 7, Bcl-2 and Interferon gamma (IFN-g) gene expression are expressed as normalised copy numbers of cytokine mRNA per 10 million b-
Actin mRNA copy numbers is plotted on y axis. PBL’s were incubated with medium alone, or stimulated with 1 μg/ml lipopolysaccharide (LPS),
or stimulated with 3 μg/ml anti-CD3 monoclonal antibody (CD3) or alternatively stimulated with 1 μg/M PMA and ionomycin. Type of
stimulation is plotted on × axis. Figure 1 a, b, c, d in vitro stimulation of PBLs from control and septic patients in absence of recombinant IL-2
(rIL-2) and Figure 1e, f, g, h in vitro stimulation of PBLs after pre-treatment of PBLs with rIL-2.
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immune paresis. The complexity of this immune paresis
suggests that immune adjuvant sepsis therapies may need
to be multimodal and provided on an individualised basis.
Conclusions
In conclusion there is a relation between aberrant gene
expression of the gc family of cytokines, and the human
immune response to infection and the onset of sepsis.
Key messages
• The occurrence of infection and sepsis are linked
with deficient IL-2 and IL-7 gene expression.
• Similar patterns of cytokine expression are
observed both in sepsis and prior to the onset of
infection.
• Onset of infection is associated with deficiency of
cytokines that regulate T cell homeostasis.
• Changes in gene expression appear to precede the
onset of clinical infection.
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